RNLX
Renalytix Plc
Set alert
0.21 USD 0.00 0.00%
0.19 Day range 0.225
0.12 52-week range 2.40
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.2098
- Prev close
- 0.2071
- Mkt cap
- 22.55M
- Vol
- 726.33K
- Avg vol
- 714.54K
- EPS
- -0.62
- P/E
- -0.33
- Div yield
- 0.00%
More statistics
- Low
- 0.19
- High
- 0.225
- Forward P/E
- -1.09
- Beta
- 2.10
- Short ratio
- 0.39
- Inst. own
- 4.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2024
- 50-d avg
- 0.269472
- 200-d avg
- 0.510152
- 1y target
- 2.50
Financial health
Altman Z-Score
-81.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.8×
FY 2018 5y median -5.3× FY 2024
P/S 11.9×
FY 2018 5y median 56.1× FY 2024
P/B -3.5×
FY 2018 5y median 13.0× FY 2024
P/FCF -0.9×
FY 2018 5y median -7.3× FY 2024
EV/EBITDA -1.1×
FY 2018 5y median -5.5× FY 2024
EV/Sales 13.5×
FY 2018 5y median 46.4× FY 2024
FCF Yield -111.0%
FY 2018 5y median -13.6% FY 2024
Profitability
Gross Margin 6.8%
FY 2018 5y median 20.6% FY 2024
Operating Margin -1293.5%
FY 2018 5y median -1293.5% FY 2024
Net Margin -1461.6%
FY 2018 5y median -1461.6% FY 2024
ROE 426.0%
FY 2018 5y median -36.5% FY 2024
ROIC -4347.7%
FY 2018 5y median -103.0% FY 2024
ROA -419.7%
FY 2018 5y median -71.6% FY 2024
Growth (YoY)
Revenue -32.7%
FY 2018 FY 2024
Operating Income 30.1%
FY 2018 FY 2024
EPS (diluted) 43.6%
FY 2018 FY 2024
Free Cash Flow 7.8%
FY 2018 FY 2024
Financial Health
Current Ratio 0.5×
FY 2018 5y median 3.9× FY 2024
Quick Ratio 0.5×
FY 2018 5y median 3.8× FY 2024
Debt / Equity -1.1×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA -0.1×
FY 2018 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2018 5y median -5539× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-06-30